Kento Fukano
Shinjuku, 1628640, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP trafficking.
Journal: Antiviral research
Published: April 21, 2025
Large-scale screening of SARS-CoV-2 variants in Tokyo, Japan: A 3-year and 9-month longitudinal survey.
Journal: Global health & medicine
Published: January 20, 2025
Evaluation of the SARS-CoV-2 RNA detection reagent LAMPdirect Genelyzer KIT using nasopharyngeal swab and saliva samples.
Journal: Diagnostic microbiology and infectious disease
Published: January 15, 2024
A versatile method to profile hepatitis B virus DNA integration.
Journal: Hepatology communications
Published: July 12, 2023
Selective inhibition of hepatitis B virus internalization by oxysterol derivatives.
Journal: Biochemical and biophysical research communications
Published: June 25, 2023
Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells.
Journal: Microbiology and immunology
Published: December 19, 2022
Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus.
Journal: Virus research
Published: September 21, 2022
Activities of endogenous APOBEC3s and uracil-DNA-glycosylase affect the hypermutation frequency of hepatitis B virus cccDNA.
Journal: The Journal of general virology
Published: April 19, 2022
NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
Journal: Journal of virology
Published: October 06, 2021
The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro.
Journal: PLoS pathogens
Published: September 25, 2021
Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus.
Journal: Biochemical and biophysical research communications
Published: May 17, 2021
MCPIP1 reduces HBV-RNA by targeting its epsilon structure.
Journal: Scientific reports
Published: February 27, 2020
Last Updated: 09/26/2026